Literature DB >> 25739491

[Genetic factors associated with dementia in Parkinson's disease (PD)].

Diego Romo-Gutiérrez1, Petra Yescas2, Marisol López-López3, Marie-Catherine Boll1.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms. Dementia is a frequent complication of idiopathic Parkinsonism or PD, usually occurring later in the protracted course of the illness. Some risk factors to develop dementia in PD are aging, severe Parkinson´s symptoms, rigid-akinetic form, hallucinations, and mild cognitive impairment documented at the first examinations. It is not yet clear if some genetic factors are either risk or protector for progression to dementia. In a review of the literature, we found that mutations in the alpha-synuclein gene are the most responsible for developing dementia, either from PARK1 or 4 mutations. GBA (glucocerebrosidase) is another accountable factor. However, the vast majority of patients suffer from non-Mendelian or complex forms of PD, which are likely caused by the combined effects of genetic and environmental factors. There is not until now a clear relation between some polymorphisms in candidate genes and cognitive deterioration, as many studies have not clearly identified this phenotype.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25739491

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  4 in total

Review 1.  The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.

Authors:  Wei-Xi Xiong; Yi-Min Sun; Rong-Yuan Guan; Su-Shan Luo; Chen Chen; Yu An; Jian Wang; Jian-Jun Wu
Journal:  J Neurol       Date:  2016-07-08       Impact factor: 4.849

2.  Rare variants in dementia genes and Parkinson's disease.

Authors:  Zafar Iqbal; Lasse Pihlstrøm; Aina Rengmark; Sandra Pilar Henriksen; Jan Linder; Lars Forsgren; Mathias Toft
Journal:  Eur J Hum Genet       Date:  2016-06-22       Impact factor: 4.246

3.  Parkinson Disease and Melanoma: Confirming and Reexamining an Association.

Authors:  Lauren A Dalvin; Gena M Damento; Barbara P Yawn; Barbara A Abbott; David O Hodge; Jose S Pulido
Journal:  Mayo Clin Proc       Date:  2017-07       Impact factor: 7.616

4.  Protective Activity of Erythropoyetine in the Cognition of Patients with Parkinson's Disease.

Authors:  Ivonne Pedroso; Marité Garcia; Enrique Casabona; Lilia Morales; Maria Luisa Bringas; Leslie Pérez; Teresita Rodríguez; Ileana Sosa; Yordanka Ricardo; Arnoldo Padrón; Daniel Amaro
Journal:  Behav Sci (Basel)       Date:  2018-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.